Global Diabetes Prevention Interventions: A Systematic Review and Network Meta-analysis of the Real-World Impact on Incidence, Weight, and Glucose
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 22 of the 49 sources its claims cite were checked for support.
Abstract
OBJECTIVE: Understanding the real-world impacts of lifestyle modification (LSM) for diabetes prevention is imperative to inform resource allocation. The purpose of this study was to synthetize global evidence on the impact of LSM strategies on diabetes incidence and risk factors in one parsimonious model. RESEARCH DESIGN AND METHODS: PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched for studies published between January 1990 and April 2015. Effectiveness/translation studies of any design testing LSM strategies, targeting high-risk populations (with prediabetes or diabetes risk factors), and reporting diabetes incidence, weight, or glucose outcomes were included. We extracted number of diabetes cases/incidence rates and mean changes in weight (kg), fasting blood glucose (FBG, mmol/L), 2-h postload glucose (mmol/L), and hemoglobin A1c (%). Pairwise random-effects and frequentist random-effects network meta-analyses were used to obtain pooled effects. RESULTS: Sixty-three studies were pooled in the meta-analysis (n = 17,272, mean age 49.7 years, 28.8% male, 60.8% white/European). In analyses restricted to controlled studies (n = 7), diabetes cumulative incidence was 9% among intervention participants and 12% among control participants (absolute risk reduction 3%; relative risk 0.71 [95% CI 0.58, 0.88]). In analyses combining controlled and uncontrolled studies (n = 14), participants receiving group education by health care professionals had 33% lower diabetes odds than control participants (odds ratio 0.67 [0.49, 0.92]). Intervention participants lost 1.5 kg more weight [−2.2, −0.8] and achieved a 0.09 mmol/L greater FBG decrease [−0.15, −0.03] than control participants. Every additional kilogram lost by participants was associated with 43% lower diabetes odds (β = 0.57 [0.41, 0.78]). CONCLUSIONS: Real-world LSM strategies can reduce diabetes risk, even with small weight reductions.
Overview
CoChat Summary
TL;DR
This systematic review and network meta-analysis found that real-world lifestyle modification strategies reduced diabetes incidence, produced modest weight loss, and improved fasting blood glucose. Group education delivered by health care professionals was associated with lower diabetes odds, and greater weight loss and session attendance predicted lower diabetes risk.
Key findings
- In controlled studies (n = 7), diabetes cumulative incidence was 9% among intervention participants vs 12% among controls (absolute risk reduction 3%; relative risk 0.71 [95% CI 0.58, 0.88]).
- In the arm-based network meta-analysis combining controlled and uncontrolled studies (n = 14), group education by health care professionals was associated with 33% lower diabetes odds vs control (OR 0.67 [0.49, 0.92]); other strategies did not show significantly lower odds.
- Intervention participants lost 1.5 kg more weight [−2.2, −0.8] and achieved a 0.09 mmol/L greater fasting blood glucose decrease [−0.15, −0.03] than control participants.
- Each additional kilogram lost was associated with 43% lower diabetes odds (β = 0.57 [0.41, 0.78]); each additional intervention session attended was associated with 18% lower odds (β = 0.82 [0.74, 0.90]); each additional month of follow-up was associated with higher odds (β = 1.06 [1.02, 1.09]).
Methods
- Systematic search of PubMed, Embase, Cochrane Library, and ClinicalTrials.gov for studies published January 1990–April 2015; eligible studies were effectiveness/translation studies of any design testing lifestyle modification in high-risk populations and reporting diabetes incidence, weight, or glucose outcomes. Seventy-seven articles met inclusion criteria, and 63 were pooled in meta-analysis (n = 17,272; mean age 49.7 years; 28.8% male; 60.8% white/European).
- Pairwise random-effects and frequentist random-effects arm-based network meta-analyses were used; intervention arms were grouped into group education by community members, group education by health care professionals, individual counseling by health care professionals, and education/counseling delivered via technology, and compared with control arms.
- Heterogeneity was assessed with I², meta-regressions, subgroup analyses, sensitivity analyses by study quality, and publication bias assessment using Egger tests and funnel plots.
Limitations
- Stated in the paper: transitivity was not achieved because studies differed in design, methods, populations, and interventions; statistical heterogeneity was over 90%; 40% of studies used a pre/post single-group design; direct and indirect evidence were compared without formal consistency tests; interventions were grouped only by delivery agent and modality; the star-shaped network did not compare intervention strategies against each other or rank them.
- Stated in the paper: publication bias was present for diabetes incidence and weight outcomes; most studies were from high-income countries; 80% of studies were low to medium quality; only 14 studies reported diabetes incidence, most with short follow-up; few studies measured glucose outcomes, and PPG and A1C showed no significant improvements.
- Evident from the text: several intervention strategies had very few arms (e.g., technology-delivered education/counseling, individual counseling), limiting statistical power and precision for those comparisons.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
13 Valid · 3 Not valid · 9 Not checked · 102 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“lifestyle modification (LSM) has been proven to prevent or at least delay type 2 diabetes and its complications in large randomized trials (2–6)”
What the sources say
- Not checked — no full text of the sourcecites [2] Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med source
- Partly supportedcites [3] Ramachandran, 2006, The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1), Diabetologia sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says randomized studies found that lifestyle modification delays or prevents progression to diabetes, and the Discussion reports lower diabetes incidence in this trial’s lifestyle group than in controls. The paper does not report that lifestyle modification prevents or delays diabetes complications; its measured outcome was diabetes onset. (LLM, conf=0.88)
- Partly supportedcites [4] Diabetes Prevention Program Research Group, 2015, Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study, Lancet Diabetes Endocrinol sourceExperimental — accuracy not yet measured
The Discussion reports that lifestyle intervention reduced or delayed diabetes over 15 years. It also says there was no significant reduction in aggregate microvascular complications in the total cohort, although women had a significant reduction. Thus this paper does not establish the claim about preventing complications without that qualification. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [5] Lindström, 2006, Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study, Lancet source
- Not checked — no full text of the sourcecites [6] Li, 2008, The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study, Lancet source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Existing meta-analyses show that LSM strategies to prevent type 2 diabetes that are delivered under real-world conditions are effective for promoting weight loss (7–11)”
What the sources say
- Supportedcites [7] Cardona-Morrell, 2010, Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis, BMC Public Health source
The Results (‘Consistency of findings with reference trials’; page not supplied) report pooled weight loss of 1.82 kg at one year in the lifestyle-intervention groups. The Results also describe adaptations of diabetes-prevention interventions for routine clinical practice, supporting the claim’s real-world setting. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [8] Ali, 2012, How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?, Health Aff (Millwood) source
- Supportedcites [9] Dunkley, 2014, Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis, Diabetes Care source
The Implications for Practice section states that the review found pragmatic lifestyle interventions effective at promoting weight loss. The Conclusions section reports a mean weight reduction of 2.1 kg at 12 months across the programs in its meta-analysis. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Supportedcites [10] Mudaliar, 2016, Cardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysis, PLoS Med source
The Methods and Findings describe a meta-analysis of DPP-based lifestyle programs delivered in US clinical, community, and online settings. The Discussion reports weight loss in these translation studies, including an additional 1.9 kg lost in intervention arms versus control arms in studies with adequate controls. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [11] Pronk, 2016, Structured diet and physical activity programmes provide strong evidence of effectiveness for type 2 diabetes prevention and improvement of cardiometabolic health, Evid Based Med source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Indeed, in our previous meta-analysis, we showed the effects of LSM strategies wane with time (38), suggesting strategies to maintain intervention effects in the long term are needed.”
What the sources say
- Supportedcites [38] Haw, 2017, Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials, JAMA Intern Med source
The Discussion states that the meta-analysis found lifestyle-modification (LSM) effects decreased over time, despite a lower diabetes risk than controls 5 to 9 years after intervention. The Abstract likewise says the effects were sustained for several years but declined with time. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We also found that every additional kilogram of weight lost was associated with lower diabetes incidence, supporting the premise that weight loss is important for diabetes prevention (12,13).”
What the sources say
- Not checked — no full text of the sourcecites [12] Abdullah, 2010, The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies, Diabetes Res Clin Pract source
- Partly supportedcites [13] Cloostermans, 2015, Independent and combined effects of physical activity and body mass index on the development of type 2 diabetes—a meta-analysis of 9 prospective cohort studies, Int J Behav Nutr Phys Act sourceExperimental — accuracy not yet measured
The Conclusions say that maintaining a healthy weight is important for reducing type 2 diabetes risk. However, the Methods assess baseline BMI rather than weight loss, so this paper supports the importance of healthy weight but does not directly establish that losing weight prevents diabetes. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In this meta-analysis, we assessed each study using a set of quality indicators previously used in meta-analyses of translation studies (8,10).”
What the sources say
- Not checked — no full text of the sourcecites [8] Ali, 2012, How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?, Health Aff (Millwood) source
- Supportedcites [10] Mudaliar, 2016, Cardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysis, PLoS Med source
The Quality Assessment section says this meta-analysis applied a three-criterion scoring system to assess the quality of translation studies. It describes the indicators, including attrition bias, control groups, and reporting on implementation, so the paper is an example of their prior use in a meta-analysis of translation studies. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
70 more claims
Create a free account to see all 127 claims and every source verdict.
- Probably not a substantial claim. 28
- It may state two separate claims as one. 31
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The translation of the structured lifestyle intervention used in the Diabetes Prevention Program to community-based programs, commercial programs, and programs using remote technologies have achieved less weight loss than observed in the Diabetes Prevention Program trial itself.861–869”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [861]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight loss of >5% improves glycaemic control, lipid levels, and BP in overweight and obese adults with T2DM.64,65”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been noted that this literature is plagued by (1) patchwork combinations of remote technologies; (2) a dearth of evidence testing d-DPPs in specific subpopulations, such as older adults; and (3) the inconsistent effects of d-DPPs on HbA1c.”
From Effects of a Digital Diabetes Prevention Program: An RCT (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been noted that this literature is plagued by (1) patchwork combinations of remote technologies; (2) a dearth of evidence testing d-DPPs in specific subpopulations, such as older adults; and (3) the inconsistent effects of d-DPPs on HbA1c.”
From Effects of a Digital Diabetes Prevention Program: An RCT (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“another meta-analysis that included 10 technology-based DPPs found no significant effects on blood glucose control.”
From Effects of a Digital Diabetes Prevention Program: An RCT (2022) · cites this paper as [12]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Results
“individual counseling (−0.6 kg”
§ Results
“[−1.1, −0.8]) by health care professionals promoted weight loss.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Conclusions
“The diabetes relative risk reduction effect we observed aligns with a previous meta-analytic estimate of translation studies (14) but is smaller than that reported in a meta-analysis from the Community Preventive Services Task Force (11). This may be explained by the fact that the former analysis included efficacy-type studies”
§ Introduction
“one meta-analysis commissioned by the Community Preventive Services Task Force showed LSM can reduce incidence, although estimates were derived from combined translation and proof-of-principle studies (11).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results
“Studies reporting PPG (n = 7) or A1C outcomes (n = 9) did not achieve significant improvements in these outcomes”
§ Results
“−23.6 mmol/mol [–24.6, −22.4]) for A1C.”
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
Feature Selection with the Boruta Package
Kursa, M. B., & Rudnicki, W. R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i11 · Cited by 5,659
Curran, G. M., Bauer, M., Mittman, B., Pyne, J. M., & Stetler, C. (2012) · Medical Care · doi:10.1097/mlr.0b013e3182408812 · Cited by 4,058 · cited 1×
“, rollout designs, hybrid designs) (40,41), and pragmatic measures (42) can be used in this endeavor.”
MethodRamachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
Li, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600
How Can We Increase Translation of Research into Practice? Types of Evidence Needed
Glasgow, R. E., & Emmons, K. M. (2007) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144145 · Cited by 1,050
Cited by
Items 101–200 of 287
Aittola, K., Karhunen, L. J., Männikkö, R., Järvelä‐Reijonen, E., Mikkonen, S. J., Absetz, P., Kolehmainen, M., Schwab, U., Harjumaa, M., Lindström, J., et al. (2021) · Nutrients · doi:10.3390/nu13114030 · Cited by 15
BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS)
Mehran, L., Mousapour, P., Khalili, D., Cheraghi, L., Honarvar, M., Amouzegar, A., & Azizi, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-22817-6 · Cited by 12
Chattopadhyay, K., Mishra, P., Singh, K., Singh, K., Harris, T. J., Hamer, M., Greenfield, S., Manjunath, N. K., Nair, R., Mukherjee, S., et al. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01395-4 · Cited by 18
Sampson, M., Clark, A., Bachmann, M. O., Garner, N. J., Irvine, L., Howe, A. C., Greaves, C. J., Auckland, S., Smith, J. R., Turner, J. J. O., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02053-x · Cited by 11
Cheng, L., Lv, C., Xue, L., Zhang, C., Wang, L., Wang, X., Chen, S., Li, X., Feng, W., Xie, H., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1462535 · Cited by 196
Eurasian clinical practice guidelines for dietary management of cardiovascular diseases (2024)
Starodubova, A. V., Chazova, I. E., Tutelyan, V. A., Nikityuk, D. B., Pavlovskaya, E. V., Кislyak, O. A., Blinova, N. V., Brumberg, A. A. B., Bubnova, M. G., Varaeva, Y. R., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-4-6-66 · Cited by 13
Approach to Lipid Management in the Patient With Diabetes
Kim, S. J., & Subramanian, S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf018 · Cited by 14
Kuang, X., Shao, X., Li, H., Jiang, D., Gao, T., Yang, J., Li, K., & Li, D. (2022) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12346 · Cited by 12
Hasandokht, T., Joukar, F., Maroufizadeh, S., Sibeveih, Z., Naghipour, M., Hedayatzadeh, Z., & Mansour‐Ghanaei, F. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01248-4 · Cited by 11
Wang, Z., Shi, Q., Zeng, Y., & Li, Y. (2023) · Journal of Clinical Nursing · doi:10.1111/jocn.16713 · Cited by 17
Gant, C. M., Mensink, I., Binnenmars, S. H., van der Palen, J. A. M., Bakker, S. J. L., Navis, G. J., & Laverman, G. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218400 · Cited by 9
Chen, M., Ukke, G. G., Moran, L., Sood, S., Bennett, C., Khomami, M. B., Absetz, P., Teede, H. J., Harrison, C. L., & Lim, S. S. (2021) · Nutrients · doi:10.3390/nu13114118 · Cited by 15
Management of patients with type 2 diabetes and MASLD: An overview and joint statement
Chouik, Y., Canivet, C. M., Julla, J., Mouillot, T., Parlati, L., Rouland, A., Smati, S., Tramunt, B., Anty, R., Boursier, J., et al. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101709 · Cited by 12
Guariguata, L., Garcia, L., Sobers, N., Ferguson, T., Woodcock, J., Samuels, T., Guell, C., & Unwin, N. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000436 · Cited by 9
Lunde, P., Skoglund, G., Olsen, C. F., Hilde, G., Bong, W. K., & Nilsson, B. B. (2023) · JMIR Human Factors · doi:10.2196/48950 · Cited by 12
Hilbert, A., Neuhaus, P., Köhler, N., Petroff, D., Hay, P., & Hübner, C. (2021) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000668 · Cited by 9
Herman, W. H., Santos, C. V., Joiner, K. L., & McEwen, L. N. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110835 · Cited by 7
Association of high-sensitivity troponin T with left ventricular dysfunction in prediabetes
Tanrıverdi, O., & Aşkın, L. (2024) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2024.2365605 · Cited by 7
An, K., Zhang, J., Wang, X., Qiao, R., & An, Z. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112188 · Cited by 9
Lower-Intensity Interventions for Prediabetes: A Systematic Review
Tseng, E., Lam, K. Y., Meza, K., O’Brien, M. J., & Maruthur, N. M. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.05.012 · Cited by 12
Weber, M. B., Rhodes, E., Ranjani, H., Jeemon, P., Ali, M. K., Hennink, M. M., Anjana, R. M., Mohan, V., Narayan, K. M. V., & Prabhakaran, D. (2023) · Implementation Science Communications · doi:10.1186/s43058-023-00516-1 · Cited by 7
Self-citationPrediction of type 2 diabetes mellitus based on nutrition data
Katsimpris, A., Aboulmaouahib, B., Rathmann, W., Peters, A., Strauch, K., & Flaquer, A. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.36 · Cited by 10
Herman, W. H., Santos, C. V., Joiner, K. L., & McEwen, L. N. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108527 · Cited by 8
Prediabetes: an unexplored cardiovascular disease risk factor
Alderman, M. H. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002644 · Cited by 7
Renoprotective Roles of Curcumin
Yaribeygi, H., Maleki, M., Majeed, M. A., Jamialahmadi, T., & Sahebkar, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73234-9_38 · Cited by 7
Rani, P. K., Williams, J. D., Jaswal, N., Yandluri, V., Sangani, P., Sanagavarapu, K., Natarajan, R., Ramalingam, S., Saligram, N., & Khanna, R. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1470615 · Cited by 12
Current treatment for diabetes: a holistic approach
Mourelatou, N. G., Kounatidis, D. C., Vallianou, N. G., Daniele, G., Dardano, A., & Rebelos, E. (2025) · HORMONES · doi:10.1007/s42000-025-00734-3 · Cited by 8
Marsden, A., Hann, M., Barron, E., McGough, B., Murray, E., Valabhji, J., & Cotterill, S. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-10365-2 · Cited by 10
Abushanab, D., Al‐Badriyeh, D., Marquina, C., Morton, J. I., Lloyd, M., Zomer, E., Talic, S., Liew, D., & Ademi, Z. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae292 · Cited by 7
Schmidt, M. I., Bracco, P. A., Nunes, M. A., Cherubini, K. A., de Castilhos, C. D., Spagiari, J. Z., Galliano, L. M., Ladwig, R., Vecchio, F. B. D., Vecchio, A. H. M. D., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082572 · Cited by 8
Narisada, A., Shibata, E., Hasegawa, T., Wakayama, R., & Suzuki, K. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109946 · Cited by 8
Diabetic Retinopathy and Diabetic Macular Edema: Fighting the Emerging Global Burden
Bhattacharjee, H., Barman, M., & Garg, M. (2022) · Springer eBooks · doi:10.1007/978-981-19-7307-9_20 · Cited by 8
Gabriel, R., Boukichou-Abdelkader, N., Gilis‐Januszewska, A., Makrilakis, K., Gómez‐Huelgas, R., Kamenov, Z. A., Paulweber, B., Satman, İ., Djordjević, P., Alkandari, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12052035 · Cited by 7
Nutritional Recommendations for the Prevention of Type 2 Diabetes Mellitus
Skurk, T., Grünerbel, A., Hummel, S., Kabisch, S., Keuthage, W., Müssig, K., Nussbaumer, H., Rubin, D., Simon, M., Tombek, A., et al. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2166-6943 · Cited by 9
Calderón-Ticona, J. R., Taype-Rondán, Á., Villamonte, G., Labán-Seminario, L. M., Helguero-Santin, L. M., Miranda, J. J., & Lazo‐Porras, M. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.11.014 · Cited by 6
Dineen, T. E., Bean, C. N., Cranston, K. D., MacPherson, M., & Jung, M. E. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.728612 · Cited by 10
Haseldine, C., O’Donoghue, G., Kearney, P. M., Riordan, F., Humphreys, M., Kirby, L., & McHugh, S. (2023) · HRB Open Research · doi:10.12688/hrbopenres.13807.1 · Cited by 5
Bower, P., Soiland‐Reyes, C., Bennett, C., Brunton, L., Burch, P., Cameron, E., Chandola, T., Chatzi, G., Cotterill, S., French, D., et al. (2025) · Health and Social Care Delivery Research · doi:10.3310/mwkj5102 · Cited by 8
Barriers to Prevention and Treatment of Type 2 Diabetes Mellitus Among Outpatients in Belarus
Sachkouskaya, A., Михайловна, Ш. Т., Kovalevskiy, D. V., Русаленко, М. Г., Savasteeva, I., Goto, A., Yokokawa, H., Kumagai, A., & Takahashi, J. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.797857 · Cited by 8
Cranston, K. D., MacPherson, M., Sim, J. A. P., & Jung, M. E. (2023) · Community Health Equity Research & Policy · doi:10.1177/2752535x231189932 · Cited by 10
Espinola, O. P., Tobias, D. K., & Manson, J. E. (2025) · American Journal of Lifestyle Medicine · doi:10.1177/15598276251372427 · Cited by 10
Weber, M. B., & Narayan, K. M. V. (2019) · Diabetes Care · doi:10.2337/dci19-0022 · Cited by 7
Self-citationMMiDaS-AE: multi-modal missing data aware stacked autoencoder for biomedical abstract screening
Lee, E. W., Wallace, B., Galaviz, K. I., & Ho, J. C. (2020) · ACM Conference on Health, Inference, and Learning (CHIL) · doi:10.1145/3368555.3384463 · Cited by 7
Self-citationOptimizing strategies to identify high risk of developing type 2 diabetes
Bracco, P. A., Schmidt, M. I., Vigo, Á., Mill, J. G., Vidigal, P. G., Barreto, S. M., de Sander, M. F., da Fonseca, M. D. J. M., & Duncan, B. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1166147 · Cited by 5
Shakya, P., Shrestha, A., Bajracharya, M., Shrestha, A., Kulseng, B. E., Karmacharya, B. M., Shrestha, S., Das, S., Shrestha, I. B., Barun, K., et al. (2023) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2023-000702 · Cited by 5
Haseldine, C., O’Donoghue, G., Kearney, P. M., Riordan, F., Kerins, C., Kirby, L., Humphreys, M., & McHugh, S. (2023) · Diabetic Medicine · doi:10.1111/dme.15277 · Cited by 6
A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus
AlHabeeb, W., Elasfar, A., Kinsara, A. J., Aljizeeri, A. H., Jelaidan, I., Alghalayini, K. W., AlKheraiji., M. F., Akbar, M. A. J., Lawand, S., Alyousif, S. M., et al. (2024) · Journal of the Saudi Heart Association · doi:10.37616/2212-5043.1407 · Cited by 11
Suhlrie, L., Ayyagari, R., Mba, C. M., Olsson, K., Torres-Aparcana, H., James, S., Vounzoulaki, E., & Ibsen, D. B. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103252 · Cited by 13
Maitland, S. B., Brauer, P. M., Mutch, D. M., Royall, D., Klein, D., Tremblay, A., Rhéaume, C., Dhaliwal, R., & Jeejeebhoy, K. N. (2021) · Nutrients · doi:10.3390/nu13124258 · Cited by 5
Brauer, P. M., Royall, D., Li, A., Rodrigues, A., Green, J., Macklin, S., Craig, A., Chan, M., Pasanen, J., Brunelle, L., et al. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00540-9 · Cited by 6
Preventing type 2 diabetes: A research agenda for behavioural science
French, D., Ahern, A. L., Greaves, C. J., Hawkes, R. E., Higgs, S., Pechey, R., & Sniehotta, F. F. (2023) · Diabetic Medicine · doi:10.1111/dme.15147 · Cited by 5
One-hour plasma glucose defining stages of type 2 diabetes − The ELSA-Brasil study
Feter, J. S., de Paula, D., Bracco, P. A., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112916 · Cited by 4
Honarvar, B., Banakar, M., Hassani, N., Movahednezhad, Y., Gheibi, Z., & Lankarani, K. B. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_161_19 · Cited by 4
Armario, P., Brotons, C., Elosúa, R., de Leciñana, M. A., Castro, A., Clarà, A. B. I., Cortés, O., Rodríguez, Á. D., Herranz, M., Justo, S., et al. (2020) · PubMed Central · Cited by 5
Odglun, Y., Sranacharoenpong, K., & Nirdnoy, N. (2023) · Journal of Health Research · doi:10.56808/2586-940x.1026 · Cited by 8
Role of LncRNA MIAT in Diabetic Complications
Wang, L., Wang, H., Luo, Y., Wu, W. L., Gui, Y., Zhao, J., Xiong, R., Li, X., Yuan, D., & Yuan, C. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230914091944 · Cited by 5
Research on Diabetes Prediction Model of Pima Indian Females
Guan, Y., Tsai, C. J., & Zhang, S. (2023) · International Symposium on Artificial Intelligence for Medicine Sciences (ISAIMS) · doi:10.1145/3644116.3644168 · Cited by 6
Murraya koenigii (L.) Spreng. as a Natural Intervention for Diabesity: A Review
Jachak, S. M., Thakur, M. S., Ahirrao, P., & Goyal, A. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128304471240801183021 · Cited by 10
Diabetes prevention: current promise and future directions
Weber, M. B. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00055-5 · Cited by 5
Self-citationWang, X., Liu, J., Huang, L., Zeng, H., He, G., Chen, L., Ma, R., Fu, W., & Ning, B. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029073 · Cited by 5
Exploring prediabetes remission in public primary care in Mexico: A cascade analysis
Silva-Tinoco, R., Castillo‐Martínez, L., Pérez-Galván, A., de la Torre-Saldaña, V., GUZMAN-OLVERA, E. B., Hinojosa-Segura, C., & Ávalos-Bracho, A. (2025) · Clinical Medicine · doi:10.1016/j.clinme.2025.100310 · Cited by 3
Lean, M. E. J. (2021) · Diabetic Medicine · doi:10.1111/dme.14643 · Cited by 3
Chlorogenic acid utilization in the diabetic and prediabetic states
Abdollahi, M., Shirkhani, S., & Marandi, S. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13868-3.00034-x · Cited by 3
Haseldine, C., Pallin, J. A., Kearney, P. M., McHugh, S., Riordan, F., Cotterill, S., & O’Donoghue, G. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090105 · Cited by 4
Prevención y tratamiento de los factores de riesgo cardiovascular
Moya, R. R. M., Ros, A. L., Al-Mahdi, E. A. R., & Gómez, J. L. Z. (2021) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2021.06.012 · Cited by 7
Александровна, Ф. О., Ea, T., Фролов, Д. Н., & Yangirova, E. K. (2022) · Problems of Social Hygiene Public Health and History of Medicine · doi:10.32687/0869-866x-2022-30-5-795-800 · Cited by 4
Attendance, Weight Loss, and Participation in a Behavioural Diabetes Prevention Programme
Poupakis, S., Kolotourou, M., MacMillan, H. J., & Chadwick, P. (2023) · International Journal of Behavioral Medicine · doi:10.1007/s12529-022-10146-x · Cited by 6
Chrysohoou, C. A., Fragoulis, C., Leontsinis, I., Gastouniotis, I., Fragouli, D., Georgopoulos, M., Mantzouranis, E., Noutsou, M., & Tsioufis, K. P. (2023) · Nutrients · doi:10.3390/nu15061384 · Cited by 3
MacPherson, M., Johnston, C., Cranston, K. D., Der, S., Sim, J. A. P., & Jung, M. E. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.02.004 · Cited by 3
Følling, I. S., Klöckner, C. A., Devle, M. T., & Kulseng, B. E. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054841 · Cited by 7
Morton, J. I., McDonald, S. P., Salim, A., Liew, D., Shaw, J. E., & Magliano, D. J. (2021) · doi:10.2337/figshare.14363783 · Cited by 3
Park, C., Larsen, B. A., Kwon, S. C., Xia, Y., LaNoue, M. D., Dickson, V. V., Reynolds, H. R., & Spruill, T. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297042 · Cited by 2
Ogurtsova, K., Laxy, M., Emmert-Fees, K. M. F., Dintsios, C., Zhang, P., & Icks, A. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004382 · Cited by 3
Bauer, J., Ayala, F. O., Marcadenti, A., Machado, R. H. V., Bersch-Ferreira, Â. C., Moreira, M. F. S., Beretta, M. V., Feóli, A. M. P., & Busnello, F. M. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22081275 · Cited by 4
Armario, P., Brotons, C., Elosúa, R., de Leciñana, M. A., Castro, A., Clarà, A. B. I., Cortés, O., Rodríguez, Á. D., Herranz, M., Justo, S., et al. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.11.004 · Cited by 7
Salmon, M. K., Gordon, N. F., Constantinou, D., Reid, K. S., Wright, B. S., Kridl, T. L., & Faircloth, G. C. (2021) · American Journal of Lifestyle Medicine · doi:10.1177/15598276211019012 · Cited by 2
Sun, C., Lei, Y., Lin, Z., Li, S., Wang, M., & Gu, J. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.16384 · Cited by 2
Assessment of Type 2 Diabetes Awareness and Knowledge in the Non-medical Bahraini Population
Khalaf, S. H., Waheed, A. S., Ali, N. A., et al. (2023) · Cureus · doi:10.7759/cureus.44231 · Cited by 2
Haseldine, C., O’Donoghue, G., Kearney, P. M., Riordan, F., Humphreys, M., Kirby, L., & McHugh, S. (2024) · HRB Open Research · doi:10.12688/hrbopenres.13807.2 · Cited by 1
Adejumo, O. A., Ogunbiyi, E. O., & Chen, L.-Y. (2024) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000601 · Cited by 3
Martínez, W. A. R., Salazar-Solarte, A. M., Sánchez-Machado, D. M., Figueroa, L., Pacheco, R., Bolaños-Moreno, Y., & Casanova, M. (2025) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-025-00224-w · Cited by 2
Pizzol, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11291-7 · Cited by 2
It is time for a more targeted approach to prediabetes in primary care in Aotearoa New Zealand
Barthow, C. A., Pullon, S., McKinlay, E. M., & Krebs, J. D. (2022) · Journal of Primary Health Care · doi:10.1071/hc22089 · Cited by 4
Haseldine, C., O’Donoghue, G., Kearney, P. M., Riordan, F., Cotterill, S., & McHugh, S. (2023) · HRB Open Research · doi:10.12688/hrbopenres.13702.1 · Cited by 4
Implementing dietary counselling in family practice for diabetes control and prevention
Abdullah, M. Y., Aljuaid, A. M., Al-Shamary, Y. W. Z., Alshammari, B. Z., Alsufyani, N. M., Alkhaldi, R. A., Alwajaan, A. M., Alenazi, H. S., Alshammari, B. T., Alrasheedi, S. N., et al. (2024) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20241313 · Cited by 1
Diabetes mellitus: Etiology and epidemiology
Beyh, Y. S., & Narayan, K. M. V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821848-8.00006-8 · Cited by 3
Self-citationMarsden, A., Hann, M., Barron, E., McGough, B., Murray, E., Valabhji, J., & Cotterill, S. (2023) · medRxiv · doi:10.1101/2023.02.21.23286221 · Cited by 2
Maleki, M., & Hosseini, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-80915-3.00012-0 · Cited by 1
Body Weight Changes and Incident Diabetes Mellitus: A Cohort Study from the Middle East
Salesi, R. (2022) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2023.64.3.2650 · Cited by 1
Sedentary Behaviour, Diabetes and the Metabolic Syndrome
Henson, J. J., Edwardson, C. L., Dempsey, P. C., Davies, M. J., & Yates, T. E. (2023) · Springer series on epidemiology and public health · doi:10.1007/978-3-031-41881-5_7 · Cited by 3
Pereira, R. A., Hey, A., JESUS, A. B. D., Marin, A. T., Fiorini, F., Corassa, R., Goes, A. K. S., GROLLI, M., Dangui, A. Z., Wouk, J., et al. (2024) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202420231369 · Cited by 1
Yaribeygi, H., Mirmohammadkhani, M., Rashidy‐Pour, A., Sathyapalan, T., Foroutan, M., Najmaldin, A., Hemmati, M. A., & Memaripanah, N. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2539252 · Cited by 2
Lee, I., Kang, M., Choi, J. H., Lim, H., & Chon, S. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0675 · Cited by 6
Jackisch, J., Noor, N., Raitakari, O. T., Lehtimäki, T. J., Kähönen, M., Cullati, S., Delpierre, C., Kivimäki, M., & Carmeli, C. (2025) · European Journal of Public Health · doi:10.1093/eurpub/ckaf212 · Cited by 4
Staging intermediate hyperglycaemia for type 2 diabetes prevention: the ELSA-Brasil study
Bracco, P. A., Schmidt, M. I., de Paula, D., Feter, J. S., Bergman, M., & Duncan, B. B. (2026) · Diabetologia · doi:10.1007/s00125-026-06743-0 · Cited by 1
Diabetes Mellitus type 2: Management and follow up in Primary Health Care Center
Alkinani, A. A., Alkhrizi, I. M., Alkathiri, S. H., Alzubaidi, H. L. A., Alghanmi, A. A., Alghanmi, A. M., Alnashri, I. A., & Alruwaili Amal Muhaysin, B. (2021) · Archives of Pharmacy Practice · doi:10.51847/mvmt9sdifp · Cited by 4
Rehabilitace a preskripce pohybové aktivity u kardiovaskulárních a vybraných interních onemocnění
Vysoký, R., & Konečný, P. (2022) · doi:10.5507/fzv.22.24461250 · Cited by 1
Borgmann, S. O., Verket, M., Gontscharuk, V., Bücker, B., Arnolds, S., Spörkel, O., Wilm, S., & Icks, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-24180-y · Cited by 1
Bennasar‐Veny, M., Abbate, M., Colom-Rosselló, M., Capitán‐Moyano, L., Hernandez-Bermudez, I. C., Ricci‐Cabello, I., Yáñez, A. M., Fernández, M. E., the ALADIM investigators, Fresneda-Genovard, S., et al. (2025) · Implementation Science · doi:10.1186/s13012-025-01438-3 · Cited by 2
Metadata
- Authors
- Galaviz, K. I., Weber, M. B., Straus, A., Haw, J. S., Narayan, K. M. V., & Ali, M. K.
- Affiliations
- Emory University (US)
- CommUnityCare Health Centers, Austin, TX
- Corresponding author
- Galaviz, Karla Ivette
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-06-14
- Volume
- 41
- Issue
- 7
- Pages
- 1526-1534
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC6463613
- OpenAlex
- W2809010899
- Semantic Scholar
- bfc5176105aee6e1227f68881b437918e7bde0e2
- Cited by
- 289
- References
- 42
- Citations by year
- 2026: 20 · 2025: 33 · 2024: 32 · 2023: 68 · 2022: 37 · 2021: 46 · 2020: 28 · 2019: 22 · 2018: 2
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institute for Health Metrics and Evaluation (UWSC7007)
- Georgia Center for Diabetes Translation Research (P30DK111024)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Keywords
- diabetes prevention, lifestyle modification, prediabetes, diabetes incidence, weight loss, fasting blood glucose, HbA1c, post-load glucose, group education, real-world effectiveness, vulnerable populations
- MeSH terms
- Blood Glucose, Body Weight, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Life Style, Male, Middle Aged, Prediabetic State, Weight Loss, Incidence, Weight Reduction Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-16, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-16 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.